- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03612089
From Structural to Functional Characteristics of the Lumbar Multifidus in Low Back Pain
October 16, 2020 updated by: Sofie Rummens, KU Leuven
To delineate the underlying mechanisms that contribute to chronic low back pain, by extending our knowledge on structural characteristics of the lumbar multifidus muscle using ultrasound muscle imaging, and by examining the association of structural features with functional performance, more precisely proprioceptive control.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leuven, Belgium, 3000
- Recruiting
- University Hospitals Leuven
-
Contact:
- Sofie Rummens, MD
- Email: sofie.rummens@uzleuven.be
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Leuven and surroudings
Description
Inclusion criteria for chronic low back pain group:
- Non-specific low back pain, during 3 or more months, without radicular leg pain
- Modified Low Back Pain Disability Questionnaire > 20%
- Indication for MRI of the lumbar spine
- No contra-indications for MRI
- Informed consent to participate
Inclusion criteria for healthy control group:
- No history of low back pain needing medical treatment or resulting in limited activity level
- Any low back pain in the previous 3 months
- Informed consent to participate
Exclusion criteria for all subjects:
- Pregnancy
- Previous trauma or surgery to spine, abdomen or pelvis
- Structural deformity (e.g. scoliosis)
- Neurological/neuromuscular/systemic disease
- Inability to lie prone for 20 minutes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Low back pain group
Individuals with non-specific chronic low back pain
|
|
Healthy control group
Healthy individuals without low back pain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lumbar multifidus muscle volume measured by 3DfUS
Time Frame: immediately after inclusion in the study
|
in patients with chronic low back pain
|
immediately after inclusion in the study
|
|
Lumbar multifidus muscle volume measured by MRI
Time Frame: immediately after inclusion in the study
|
in patients with chronic low back pain
|
immediately after inclusion in the study
|
|
Cross-sectional area of the lumbar multifidus
Time Frame: immediately after inclusion in the study
|
measured by classic 2D-ultrasound in patients with chronic low back pain and healthy controls
|
immediately after inclusion in the study
|
|
Thickness of the lumbar multifidus
Time Frame: immediately after inclusion in the study
|
measured by classic 2D-ultrasound in patients with chronic low back pain and healthy controls
|
immediately after inclusion in the study
|
|
Proprioceptive postural control strategies in patients with low back pain with healthy controls
Time Frame: immediately after inclusion in the study
|
Mean center-of-pressure displacement in response to soleus muscle and/or multifidus muscle vibration (60 Hz, 0.5 mm) during upright standing on two support surfaces.
|
immediately after inclusion in the study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 27, 2020
Primary Completion (Anticipated)
May 1, 2021
Study Completion (Anticipated)
May 1, 2021
Study Registration Dates
First Submitted
July 26, 2018
First Submitted That Met QC Criteria
July 26, 2018
First Posted (Actual)
August 2, 2018
Study Record Updates
Last Update Posted (Actual)
October 19, 2020
Last Update Submitted That Met QC Criteria
October 16, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- s60404
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.